BFC Planning, Inc.’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Buy
13,646
+3,131
+30% +$3.2M 0.67% 21
2026
Q1
$9.7M Buy
10,515
+191
+2% +$194K 0.43% 41
2025
Q4
$11.1M Buy
10,324
+4,903
+90% +$4.69M 0.49% 36
2025
Q3
$4.14M Buy
5,421
+267
+5% +$199K 0.3% 64
2025
Q2
$4.02M Buy
5,154
+244
+5% +$190K 0.32% 60
2025
Q1
$4.06M Sell
4,910
-206
-4% -$171K 0.36% 57
2024
Q4
$3.95M Buy
+5,116
New +$4.24M 0.33% 58

Other funds holding LLY

BFC Planning, Inc.'s LLY Position: Q2 2026 in Review

BFC Planning, Inc. increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $3.2M and bringing the position to 13,646 shares worth $16.4M. The position accounts for 0.67% of the portfolio, ranked #21.

BFC Planning, Inc. first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,658 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BFC Planning, Inc. held 13,646 shares of Eli Lilly worth $16.4M as of Q2 2026.
  • BFC Planning, Inc. bought 3,131 Eli Lilly shares in Q2 2026, an estimated $3.2M.
  • Eli Lilly made up 0.67% of BFC Planning, Inc.'s portfolio in Q2 2026, its #21 holding.
  • BFC Planning, Inc. first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,658 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.